Novel tetralin derivatives
CA 2007261 C · Owner: Merrell Dow Pharmaceuticals Inc. · Inventors: Tarnus, Celine; D' Orchymont, Hugues
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to novel derivatives of tetralin namely 3-amino-naphthalene-2-one derivatives of the general formula, (see above formula I), the enantiomeric forms and mixtures thereof to the processes for, their preparation to their use as amino-peptidase inhibitors and to their end-use application as immunomodulators and as analgesic agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 5, 1990 and granted April 11, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 5, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 5, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.